Pheochromocytomas detected by biochemical screening in predisposed subjects are associated with lower prevalence of clinical and biochemical manifestations and smaller tumors than pheochromocytomas detected by signs and symptoms

European Journal of Endocrinology

Volumn 163, Issue 1, 2010, Pages 121-127

  Van Duinen, N ^a   Steenvoorden, D ^a   Bonsing, B A ^a   Vuyk, J ^a   Vriends, A H J T ^a   Jansen, J C ^a   Romijn, J A ^a   Corssmit, E P M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CANCER SUSCEPTIBILITY; CATECHOLAMINE EXCRETION; CLINICAL ARTICLE; CLINICAL FEATURE; DIAPHORESIS; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HEART PALPITATION; HUMAN; MALE; NAUSEA; PALLOR; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TUMOR VOLUME; VOMITING;

ADRENAL GLAND NEOPLASMS; ADULT; AGED; HUMANS; MIDDLE AGED; PHEOCHROMOCYTOMA; RETROSPECTIVE STUDIES;

EID: 77954120802     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0114     Document Type: Article

References (28)

1. DeLellis RA, Lloyd RV, Heitz PU & Eng C. Pathology and Genetics: WHO Classification of Tumours of Endocrine Organs Oxford, UK: Oxford University Press, 2004.
2. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C & European-American Paraganglioma Study Group . Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. Journal of the American Medical Association 2004 292 943-951.
3. Opocher G, Schiavi F, Conton P, Scaroni C & Mantero F. Clinical and genetic aspects of phaeochromocytoma. Hormone Research 2003 59 56-61.
4. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K, Januszewicz A, Eng C, Smith WM, Munk R, Manz T, Glaesker S, Apel TW, Treier M, Reineke M, Walz MK, Hoang-Vu C, Brauckhoff M, Klein-Franke A, Klose P, Schmidt H, Maier-Woelfle M, Peçzkowska M, Szmigielski C, Eng C & Freiburg-Warsaw-Columbus Pheochromocytoma Study Group . Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 2002 346 1459-1466.
5. Gagel RF, Tashjian AH Jr, Cummings T, Papathanasopoulos N, Kaplan MM, DeLellis RA, Wolfe HJ & Reichlin S. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. New England Journal of Medicine 1988 318 478-484. (Pubitemid 18054294)
6. Walther MM, Reiter R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM, Zbar B & Linehan WM. Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. Journal of Urology 1999 162 659-664. (Pubitemid 29436843)
7. Walther MM, Herring J, Enquist E, Keiser HR & Linehan WM. von Recklinghausen's disease and pheochromocytomas. Journal of Urology 1999 162 1582-1586.
8. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, Chabre O, Chamontin B, Delemer B, Giraud S, Murat A, Niccoli-Sire P, Richard S, Rohmer V, Sadoul JL, Strompf L, Schlumberger M, Bertagna X, Plouin PF, Jeunemaitre X & Gimenez-Roqueplo AP. Genetic testing in pheochromocytoma or functional paraganglioma. Journal of Clinical Oncology 2005 23 8812-8818.
9. Lenders JW, Eisenhofer G, Mannelli M & Pacak K. Phaeochromocytoma. Lancet 2005 366 665-675.
10. van Houtum WH, Corssmit EP, Douwes Dekker PB, Jansen JC, van der Mey AG, Bröcker-Vriends AH, Taschner PE, Losekoot M, Frölich M, Stokkel MP, Cornelisse CJ & Romijn JA. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas. European Journal of Endocrinology 2005 152 87-94. (Pubitemid 40185456)
11. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, Grossman AB, Kimura N, Mannelli M, McNicol AM, Tischler AS & International Symposium on Pheochromocytoma. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature Clinical Practice. Endocrinology and Metabolism 2007 3 92-102.
12. Willemsen JJ, Ross HA, Wolthers BG, Sweep CG & Kema IP. Evaluation of specific high-performance liquid-chromatographic determinations of urinary metanephrine and normetanephrine by comparison with isotope dilution mass spectrometry. Annals of Clinical Biochemistry 2001 38 722-730.
13. Pomares FJ, Canas R, Rodriguez JM, Hernandez AM, Parrilla P & Tebar FJ. Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma. Clinical Endocrinology 1998 48 195-200. (Pubitemid 28091051)
14. Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F & Maher ER. Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD. Human Mutation 2010 31 41-51.
15. Eisenhofer G, Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JW & Pacak K. Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. Journal of Clinical Endocrinology and Metabolism 2001 86 1999-2008. (Pubitemid 32472911)
16. Patocs A, Karadi E, Toth M, Varga I, Szucs N, Balogh K, Majnik J, Glaz E & Racz K. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre. European Journal of Cancer Prevention 2004 13 403-409. (Pubitemid 39336605)
17. Mannelli M, Ianni L, Cilotti A & Conti A. Pheochromocytoma in Italy: a multicentric retrospective study. European Journal of Endocrinology 1999 141 619-624. (Pubitemid 30064762)
18. Milardovic R, Corssmit EP & Stokkel M. Value of I-MIBG scintigraphy in paraganglioma. Neuroendocrinology 2009 91 94-100.
19. Miskulin J, Shulkin BL, Doherty GM, Sisson JC, Burney RE & Gauger PG. Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 2003 134 918-922.
20. Mozley PD, Kim CK, Mohsin J, Jatlow A, Gosfield E III & Alavi A. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. Journal of Nuclear Medicine 1994 35 1138-1144. (Pubitemid 24204114)
21. Van Der Horst-Schrivers AN, Jager PL, Boezen HM, Schouten JP, Kema IP & Links TP. Iodine-123 meta-iodobenzylguanidine scintigraphy in localising phaeochromocytomas - experience and meta-analysis. Anticancer Research 2006 26 1599-1604.
22. Wiseman GA, Pacak K, O'Dorisio MS, Neumann DR, Waxman AD, Mankoff DA, Heiba SI, Serafini AN, Tumeh SS, Khutoryansky N & Jacobson AF. Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial. Journal of Nuclear Medicine 2009 50 1448-1454.
23. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G & Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. Journal of Clinical Endocrinology and Metabolism 2005 90 2110-2116. (Pubitemid 40586247)
24. Kopetschke R, Slisko M, Kilisli A, Tuschy U, Wallaschofski H, Fassnacht M, Ventz M, Beuschlein F, Reincke M, Reisch N & Quinkler M. Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. European Journal of Endocrinology 2009 161 355-361.
25. Noshiro T, Shimizu K, Watanabe T, Akama H, Shibukawa S, Miura W, Ito S & Miura Y. Changes in clinical features and long-term prognosis in patients with pheochromocytoma. American Journal of Hypertension 2000 13 35-43. (Pubitemid 30103862)
26. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS & Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? Journal of the American Medical Association 2002 287 1427-1434.
27. Havekes B, van der Klaauw AA, Weiss MM, Jansen JC, van der Mey AGL, Vriends AHJT, Bonsing BA, Romijn JA & Corssmit EPM. Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas. Endocrine-Related Cancer 2009 16 527-536.
28. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, Ayala-Ramirez M & Jimenez C. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. Journal of Clinical Endocrinology and Metabolism 2010 95 2023-2037.